First Capital Advisors Group’s Vertex Pharmaceuticals VRTX Stock Holding History

First Capital Advisors Group's VRTX Position: Q2 2023 in Review

First Capital Advisors Group increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2023, buying an estimated $24.9K and bringing the position to 748 shares worth $263K. The position accounts for 0.14% of the portfolio, ranked #116.

First Capital Advisors Group first reported a position in VRTX in Q1 2018 and has held it in 4 quarters since. 1,285 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.

• First Capital Advisors Group held 748 shares of Vertex Pharmaceuticals worth $263K as of Q2 2023.
• First Capital Advisors Group bought 74 Vertex Pharmaceuticals shares in Q2 2023, an estimated $24.9K.
• Vertex Pharmaceuticals made up 0.14% of First Capital Advisors Group's portfolio in Q2 2023, its #116 holding.
• First Capital Advisors Group first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 4 quarters since.
• 1,285 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.